About Companion AST
Companion AST is a Healthcare company based in San Jose (United States) founded in 2018. Provider of imaging platform for antibiotic susceptibility tests for multi-drug resistant bacteria. Its Indian entity Uscope Compast Astechnologies Private Limited reported revenue of ₹19.3 Lakh. Its focus areas include Life Sciences, Infectious Diseases, In Vitro Diagnostic Tests and Diversified. Similar companies include PathAI, Inflammatix and Deepcell; 3 of its 3 listed similar companies have raised funding.
Company details
Companion AST was founded in 2018 and is based in San Jose, United States. An imaging platform is developed by the company for conducting antibiotic susceptibility tests on multi-drug resistant bacteria. Phenotypic characteristics of resistant strains are diagnosed through this technology, while superbugs and various clinical microbiological assays are analyzed. Operations focus on the biotechnology and healthcare sectors, supporting diagnostic processes in microbiology.
- Headquarters San Jose, United States
- SectorsHealthcare
- Website companionast.com
- Legal Name Uscope Compast Astechnologies Private Limited
- Date of Incorporation 01 Mar, 2018
- Jurisdiction Jalandhar, Punjab, India
- Indian entity revenue₹19.3 Lakh
FY 2020 · -44% YoY
- Indian entity net profit₹15,634
FY 2020 · 1% margin
- Indian entity EBITDA-₹11.7 Lakh
FY 2020 · -61% margin
Associated legal entities of Companion AST
Companion AST operates through Uscope Compast Astechnologies Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2020) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Uscope Compast Astechnologies Private Limited CIN U74999PB2018PTC047510 | Active | 01 Mar 2018 | Jalandhar, Punjab | ₹0.2 Cr | 2 | View details |
Board of directors of Uscope Compast Astechnologies Private Limited (Companion AST)
Uscope Compast Astechnologies Private Limited is the primary company behind Companion AST. The board of Uscope Compast Astechnologies Private Limited currently have 2 directors; the longest-serving is Chander Mohan Syal, appointed in 2018. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Chander Mohan Syal DIN 08045052 | Director | 01 Mar 2018 | 8 yrs 8 mo | Uscope Compast Astechnologies Private Limited |
| Indu Syal DIN 10913948 | Director | 08 Jan 2025 | 1 yr 10 mo | Uscope Compast Astechnologies Private Limited |
Financials of Companion AST
Figures of Uscope Compast Astechnologies Private Limited, the primary company behind Companion AST, for FY 2020. Revenue was ₹19.3 Lakh (-44% year on year). Net profit was ₹15,634 (1% margin). EBITDA was -₹11.7 Lakh (-61% margin).
- ₹19.3 LakhRevenue · FY 2020 · -44% YoY
- ₹15,634Net profit · 1% margin
- -₹11.7 LakhEBITDA · -61% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Uscope Compast Astechnologies Private Limited are on its company page.
Detailed financial statements for Companion AST
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Companion AST
Companion AST has 3 listed similar companies in our database, 3 of them funded. They include PathAI, Inflammatix and Deepcell.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pathai.com | 2016 | Boston, United States | $254.94M | 573 | Provider of AI-based solutions for clinical diagnosis of cancer and other diseases | |
| inflammatix.com | 2016 | San Francisco, United States | $191.47M | 54 | Provider of diagnostic solutions for systemic infections | |
| deepcell.com | 2015 | Mountain View, United States | $122.99M | 94 | AI-powered single cell classification and isolation technology for clinical research |
Detailed similar companies of Companion AST
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Companion AST (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Companion AST
Companion AST was founded in 2018.
Companion AST is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
The primary company behind Companion AST, Uscope Compast Astechnologies Private Limited, reported revenue of ₹19.3 Lakh for FY 2020, down 44% year on year.
Companion AST was founded in 2018 and is based in San Jose, United States. An imaging platform is developed by the company for conducting antibiotic susceptibility tests on multi-drug resistant bacteria. Phenotypic characteristics of resistant strains are diagnosed through this technology, while superbugs and various clinical microbiological assays are analyzed. Operations focus on the biotechnology and healthcare sectors, supporting diagnostic processes in microbiology.
Companion AST's top competitors include Inflammatix, PathAI and Deepcell.
Companion AST operates through Uscope Compast Astechnologies Private Limited.
The legal entities of Companion AST currently have 2 directors, including Chander Mohan Syal, Indu Syal.